Market Overview

Options Brief: Keryx Biopharmaceuticals, Inc (KERX)

Shares of Keryx Biopharmaceuticals, Inc (NASDAQ: KERX) are higher on the session by 6.70%, trading at $4.62.

Overall call volume is now running at 2.31x the daily average, with 67% of all calls traded being purchases on the offer. 1,245 contracts have traded on the session so far.

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.

Posted-In: Options

 

Most Popular

Related Articles (KERX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters